XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows Unaudited - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows From Operating Activities:    
Net (loss) income $ (4,259,000) $ 28,949,000
Reconciliation of net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 27,379,000 30,768,000
Goodwill impairment 36,808,000 0
Stock-based compensation 4,218,000 5,564,000
Gain on sale of property and equipment (1,562,000) (38,000)
Contingent earnout adjustments 3,246,000 0
Changes in operating assets and liabilities:    
Accounts receivable, net (9,329,000) (7,352,000)
Unbilled revenues, net (23,537,000) (18,990,000)
Accrued or prepaid income taxes (23,162,000) (8,627,000)
Accounts payable and accrued liabilities (20,612,000) 6,798,000
Deferred revenues (191,000) 2,130,000
Accrued retirement costs (1,684,000) (13,243,000)
Prepaid expenses and other operating activities (3,510,000) (5,916,000)
Net cash (used in) provided by operating activities (16,195,000) 20,043,000
Cash Flows From Investing Activities:    
Acquisitions of property and equipment (4,983,000) (5,251,000)
Capitalization of computer software costs (19,933,000) (15,372,000)
Proceeds from settlement of life insurance policies 0 4,937,000
Payments for business acquisitions, net of cash acquired (26,309,000) (23,141,000)
Cash proceeds from sale of property and equipment 3,032,000 0
Net cash used in investing activities (48,193,000) (38,827,000)
Cash Flows From Financing Activities:    
Cash dividends paid (8,938,000) (9,577,000)
Repurchases of common stock (26,749,000) (6,076,000)
Increases in revolving credit facility borrowings 99,952,000 58,449,000
Payments on revolving credit facility borrowings (15,129,000) (31,808,000)
Payments of contingent consideration on acquisitions (2,118,000) (1,683,000)
Other financing activities (87,000) 629,000
Net cash provided by financing activities 46,931,000 9,934,000
Effects of exchange rate changes on cash and cash equivalents (2,351,000) 1,123,000
Decrease in Cash, Cash Equivalents, and Restricted Cash (19,808,000) (7,727,000)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Year 53,689,000 44,656,000
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 33,881,000 $ 36,929,000